Evonik Industries AG

Evonik Industries AG

EVKIY
Evonik Industries AGUS flagOther OTC
9.22
USD
+0.11
- -
8.59BMarket Cap
Evonik Industries AG
EVKIY
(Other OTC)

Recent

price

9.22

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
14.27
15.6
14.34
13.64
13.86
14.49
13.66
15.43
14.23
14.06
13.09
16.05
19.84
16.38
16.26
15.1
15.85
Revenue per Share
0.79
1.08
1.25
2.2
0.61
1.06
0.91
0.77
1
2.26
0.5
0.8
0.58
-0.5
0.24
0.28
0.46
Basic EPS, GAAP
1.4
0.45
0.55
-0.03
-0.03
1.13
0.88
0.55
0.87
0.47
0.83
1
0.84
0.86
0.94
0.75
0.55
Free Cash Flow per Basic Share
0.34
0.43
0.46
0.46
0.5
0.5
0.58
0.58
0.58
0.58
0.58
0.58
0.58
0.58
0.58
0.58
0.59
Dividend per Share
0.5
0.5
4.73
6.45
5.91
6.75
6.63
6.95
7.19
8.38
7.88
8.83
10.53
8.61
8.47
8.2
8.58
Book Value per Share
2.66
2.31
2.42
4.08
3.67
4.73
4.76
1.52
1.81
3.44
2.38
3.57
5.74
3.71
3.79
3.3
3.65
Tangible Book Value per Share
932
932
932
932
932
932
932
932
932
932
932
932
932
932
932
932
928
Basic Weighted Avg Shares
13,300
14,540
13,365
12,708
12,917
13,507
12,732
14,383
13,267
13,108
12,199
14,955
18,488
15,267
15,157
14,069
14,707
Sales/Revenue/Turnover
10.07
12.95
14.25
9.55
8.95
12.13
10.68
8.84
8.5
8.94
6.89
8.22
6.8
-0.65
4.22
4.56
5.66
Operating Margin (%)
799
785
745
638
656
764
747
923
787
984
1,018
1,073
1,568
1,841
1,117
1,203
1,102
Depreciation Expense
734
1,011
1,165
2,054
568
991
844
713
932
2,106
465
746
540
-465
222
265
424
Net Income, GAAP
17.95
29.23
29.11
27.69
29.93
29.29
32.21
28.57
20.81
18.87
26.46
29.12
39.98
- -
44.7
34.36
28.78
Effective Tax Rate (%)
5.52
6.95
8.72
16.16
4.4
7.34
6.63
4.96
7.02
16.07
3.81
4.99
2.92
-3.05
1.46
1.88
2.88
Profit Margin (%)
3,357
2,469
1,464
2,457
2,512
3,609
5,607
2,143
2,239
3,054
2,037
2,118
3,017
1,856
1,449
1,639
1,727
Working Capital
2,867
2,745
1,464
625
632
1,359
3,230
3,694
3,684
3,701
3,541
3,478
4,041
3,312
2,944
3,295
- -
LT Debt
5,969
5,421
5,460
6,836
6,522
7,576
7,745
7,519
7,825
9,060
8,099
9,372
11,056
8,986
9,100
8,174
8,559
Total Equity
11.48
14.54
15.37
10.19
10.05
13.74
8.92
7.93
7.66
7.51
4.82
6.85
5.19
- -
2.65
3.31
6.7
Return on Invested Capital (%)
22.28
33.41
25.29
30.4
10.68
16
11.14
8.55
10.07
19.68
4.88
7.03
4.59
- -
2.66
3.4
7.02
Return on Capital (%)
157.51
216.95
47.81
39.42
9.86
16.81
13.54
11.27
14.14
29.03
6.14
9.58
5.99
-5.22
2.79
3.41
5.35
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
837
- -
- -
LT Borrowings
2,198
- -
- -
LT Finance Leases
746
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
466
466
466
Market Capitalization
8,143
9,436
8,110

Working Capital

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
5,508
6,368
5,600
Cash, Cash Equivalents & STI
618
1,307
846
Accounts Receivable, Net
1,632
1,732
1,625
Inventories
2,662
2,751
2,649
Total Current Liabilities
4,059
4,175
3,873
Payables & Accruals
- -
- -
- -
ST Debt
837
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.46%
1.21%
-10.18%
Free Cash Flow
2.37%
-0.87%
-20.39%
Net Income, GAAP
-23.32%
-56.33%
19.37%
Sales/Revenue/Turnover
1.22%
4.18%
-7.18%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,796
3,930
3,832
3,599
15,157
2025
3,777
3,499
3,403
- -
14,069
2026
3,427
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.17
- -
0.24
- -
0.24
2025
0.25
0.13
- -
- -
0.28
2026
0.13
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.55
- -
- -
0.58
2025
- -
0.59
- -
- -
0.58
2026
- -
- -
- -
- -
- -
Business
Evonik Industries AG is a leading global specialty chemicals company that develops, produces, and markets a broad portfolio of performance products and solutions for various industries. The company offers products including specialty additives such as silica, matting agents, and functional fillers; high-performance polymers like polyamides, polyurethanes, and specialty methacrylates; surfactants, monomers, and cross-linking agents; active pharmaceutical ingredients and excipients; animal nutrition solutions comprising methionine and specialty feed additives; and personal care ingredients like lipid layer enhancers and mild surfactants. Evonik serves diverse sectors including automotive, construction, healthcare, agriculture, consumer goods, and energy, with operations spanning more than 100 countries and major production sites in Europe, Asia, and the Americas. Founded in 2007 through the restructuring of former Degussa and RAG assets, Evonik is headquartered in Essen, Germany. The company operates through three key segments: Specialty Additives, which provides solutions for enhanced material performance; Nutrition & Care, focusing on health-oriented products for human and animal nutrition as well as personal and home care; and Smart Materials, delivering advanced polymers and materials for coatings, adhesives, and composites. It targets industrial manufacturers, pharmaceutical firms, agricultural businesses, and consumer product companies worldwide, with subsidiaries including Evonik Operations GmbH and a network of international joint ventures. In recent developments, Evonik announced a strategic partnership with RWE in 2024 to advance carbon capture and storage technologies for sustainable chemical production. The company also completed the acquisition of the antimicrobial coatings business from BioCote Ltd. in early 2025, expanding its hygiene solutions portfolio. Additionally, Evonik launched a new line of bio-based performance additives for the coatings industry in late 2024 and secured a EUR 500 million financing round for green hydrogen projects, supporting its commitment to sustainability and circular economy initiatives.

Company News

APIChatGPT
  • Evonik Industries AG (EVKIY) Shareholder/Analyst Call Transcript

  • Evonik Industries AG (EVKIY) Q1 2026 Earnings Call Transcript

  • Evonik Industries AG (EVKIY) Q4 2025 Earnings Call Transcript

  • Evonik Industries AG (EVKIY) Q3 2025 Earnings Call Transcript

  • Evonik: Revised Outlook Necessitates A Q3 2025 Update

  • Look Beyond The Volatility In Evonik Industries

  • Evonik Industries AG (EVKIF) Q2 2025 Earnings Call Transcript

  • Evonik Industries AG (EVKIF) Q1 2025 Earnings Call Transcript

  • Evonik: Decent Rate Of Return, Upside Confirmed

  • Evonik Industries AG (EVKIF) Q4 2024 Earnings Call Transcript

  • Evonik: A Good Company, Upside Less Clear Than Before

  • Evonik Industries AG (EVKIF) Q3 2024 Earnings Call Transcript

  • Evonik - I Continue To Be Long Here

  • Evonik: Another Exit In A Low Margin Division

  • Evonik says recovery unlikely in 2024, plans 2,000 job cuts

  • Evonik: The Reversal Could Be Significant, 'Buy'

  • Germany's Economy Is in a Bad Slump. These 6 Stocks Could Rebound.

  • Evonik Industries AG (EVKIF) Q3 2023 Earnings Conference Call Transcript

  • Evonik Industries AG (EVKIF) Q2 2023 Earnings Call Transcript

  • Evonik: A Slow Q1, But There Are Underlying Signs Of Improvement